HealthEquity Inc. (HQY)
HealthEquity Statistics
Share Statistics
HealthEquity has 86.5M shares outstanding. The number of shares has increased by 0.59% in one year.
Shares Outstanding | 86.5M |
Shares Change (YoY) | 0.59% |
Shares Change (QoQ) | -0.76% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 84.38M |
Failed to Deliver (FTD) Shares | 18.4K |
FTD / Avg. Volume | 1.88% |
Short Selling Information
The latest short interest is 4.27M, so 4.93% of the outstanding shares have been sold short.
Short Interest | 4.27M |
Short % of Shares Out | 4.93% |
Short % of Float | 5.05% |
Short Ratio (days to cover) | 6.7 |
Valuation Ratios
The PE ratio is 99.19 and the forward PE ratio is 28.61. HealthEquity's PEG ratio is 1.4.
PE Ratio | 99.19 |
Forward PE | 28.61 |
PS Ratio | 7.99 |
Forward PS | 4.8 |
PB Ratio | 4.54 |
P/FCF Ratio | 28.4 |
PEG Ratio | 1.4 |
Enterprise Valuation
HealthEquity Inc. has an Enterprise Value (EV) of 7B.
EV / Earnings | 72.35 |
EV / Sales | 5.83 |
EV / EBITDA | 20.63 |
EV / EBIT | 43.1 |
EV / FCF | 20.71 |
Financial Position
The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.06 |
Quick Ratio | 3.06 |
Debt / Equity | 0.02 |
Total Debt / Capitalization | 2.41 |
Cash Flow / Debt | 6.51 |
Interest Coverage | 2.68 |
Financial Efficiency
Return on equity (ROE) is 0.05% and return on capital (ROIC) is 6.24%.
Return on Equity (ROE) | 0.05% |
Return on Assets (ROA) | 0.03% |
Return on Capital (ROIC) | 6.24% |
Revenue Per Employee | $386,400.64 |
Profits Per Employee | $31,144.28 |
Employee Count | 3,105 |
Asset Turnover | 0.35 |
Inventory Turnover | n/a |
Taxes
Income Tax | 19.33M |
Effective Tax Rate | 0.17 |
Stock Price Statistics
The stock price has increased by 8.24% in the last 52 weeks. The beta is 0.62, so HealthEquity's price volatility has been higher than the market average.
Beta | 0.62 |
52-Week Price Change | 8.24% |
50-Day Moving Average | 103.38 |
200-Day Moving Average | 90.28 |
Relative Strength Index (RSI) | 34.9 |
Average Volume (20 Days) | 979.8K |
Income Statement
In the last 12 months, HealthEquity had revenue of 1.2B and earned 96.7M in profits. Earnings per share was 1.11.
Revenue | 1.2B |
Gross Profit | 777.26M |
Operating Income | 162.33M |
Net Income | 96.7M |
EBITDA | 339.12M |
EBIT | 162.33M |
Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 295.95M in cash and 52.22M in debt, giving a net cash position of 243.73M.
Cash & Cash Equivalents | 295.95M |
Total Debt | 52.22M |
Net Cash | 243.73M |
Retained Earnings | 0 |
Total Assets | 3.45B |
Working Capital | 321.43M |
Cash Flow
In the last 12 months, operating cash flow was 339.86M and capital expenditures -2.08M, giving a free cash flow of 337.77M.
Operating Cash Flow | 339.86M |
Capital Expenditures | -2.08M |
Free Cash Flow | 337.77M |
FCF Per Share | 3.89 |
Margins
Gross margin is 64.78%, with operating and profit margins of 13.53% and 8.06%.
Gross Margin | 64.78% |
Operating Margin | 13.53% |
Pretax Margin | 9.67% |
Profit Margin | 8.06% |
EBITDA Margin | 28.27% |
EBIT Margin | 13.53% |
FCF Margin | 28.15% |
Dividends & Yields
HQY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 1.26% |
FCF Yield | 4.42% |
Analyst Forecast
The average price target for HQY is $110, which is 24.5% higher than the current price. The consensus rating is "Buy".
Price Target | $110 |
Price Target Difference | 24.5% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Scores
Altman Z-Score | 4.16 |
Piotroski F-Score | 6 |